Molecular and pharmacodynamic properties of estrogenic extracts from the traditional Chinese medicinal herb, Epimedium

Journal of Ethnopharmacology

Volumn 113, Issue 2, 2007, Pages 218-224

  Yap, S P ^a   Shen, P ^a   Li, J ^a   Lee, L S ^b   Yong, E L ^a  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

Epimedium; Estradiol valerate; Estrogenic activity; Pharmacodynamic; Rat

Indexed keywords

EPIMEDIUM EXTRACT; ESTRADIOL VALERATE; ESTROGEN RECEPTOR ALPHA; MESSENGER RNA; PROGESTERONE RECEPTOR; PROTEIN; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CELL ASSAY; CELL STRAIN MCF 7; CHINESE MEDICINE; CONTROLLED STUDY; EPIMEDIUM; ESTROGEN ACTIVITY; ESTROGEN THERAPY; ETHNOPHARMACOLOGY; HELA CELL; HORMONAL REGULATION; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN EXPRESSION; RAT; RECEPTOR GENE;

ADMINISTRATION, ORAL; ANIMALS; AREA UNDER CURVE; BLOTTING, WESTERN; CARRIER PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; EPIMEDIUM; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; HUMANS; MALE; MICROSCOPY, CONFOCAL; PHYTOESTROGENS; PLANT EXTRACTS; PLANT LEAVES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TAMOXIFEN;

EPIMEDIUM; EPIMEDIUM BREVICORNUM; RATTUS;

EID: 34547822878     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2007.05.029     Document Type: Article

References (29)

1. Anderson G.L., et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the women's health initiative randomized controlled trial. Journal of the American Medical Association 291 (2004) 1701-1712
2. Anon. The State Pharmacopoeia of the People's Republic of China vol. 1 (2000), Chemical Industry Press, Beijing English edition
3. Anupongsanugool E., Teekachunhatean S., Rojanasthien N., Pongsatha S., and Sangdee C. Pharmacokinetics of isoflavones, daidzein and genistein, after ingestion of soy beverage compared with soy extract capsules in postmenopausal Thai women. BMC Clinical Pharmacology 5 (2005) 2
4. Beck V., Rohr U., and Jungbauer A. Phytoestrogens derived from red clover: an alternative to estrogen replacement therapy?. Journal of Steroid Biochemistry and Molecular Biology 94 (2005) 499-518
5. Bloedon L.T., Jeffcoat A.R., Lopaczynski W., Schell M.J., Black T.M., Dix K.J., Thomas B.F., Albright C., Busby M.G., Crowell J.A., and Zeisel S.H. Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women. American Journal of Clinical Nutrition 76 (2002) 1126-1137
6. Franke A.A., Custer L.J., and Hundahl S.A. Determinants for urinary and plasma isoflavones in humans after soy intake. Nutrition and Cancer 50 (2004) 141-154
7. Hillis D.M., and Dixon M.T. Ribosomal DNA: molecular evolution and phylogenetic inference. Quarterly Reviews in Biology 66 (1991) 411-453
8. Li S.Z. Ying Yang. Ben Cao Gang Mu (1991), Xue Yuan Publishing House, Beijing, China
9. Lim L.S., Shen P., Gong Y.H., and Yong E.L. Dimeric progestins from rhizomes of Ligusticum chuanxiong. Phytochemistry 67 (2006) 728-734
10. Mclntosh J., and Blalock S.J. Effects of media coverage of women's health initiative study on attitudes and behavior of women receiving hormone replacement therapy. American Journal of Health and Systems Pharmacology 62 (2005) 69-74
11. Meng F.H., Li Y.B., Xiong Z.L., Jiang Z.M., and Li F.M. Osteoblastic proliferate activity of Epimedium brevicornum Maxim. Phytomedicine 12 (2005) 189-193
12. Oh D.S., Troester M.A., Usary J., Hu Z., He X., Fan C., Wu J., Carey L.A., and Perou C.M. Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers. Journal of Clinical Oncology 2 (2006) 1656-1664
13. O'Malley B.W. A life-long search for the molecular pathways of steroid hormone action. Molecular Endocrinology 19 (2005) 1402-1411
14. Overk C.R., Yao P., Chadwick L.R., Nikolic D., Sun Y., Cuendet M.A., Deng Y., Hedayat A.S., Pauli G.F., Farnsworth N.R., van Breemen R.B., and Bolton J.L. Comparison of the in vitro estrogenic activities of compounds from hops (Humulus lupulus) and red clover (Trifolium pratense). Journal of Agricultural and Food Chemistry 53 (2005) 6246-6253
15. Petz L.N., Ziegler Y.S., Schultz J.R., Kim H., Kemper J.K., and Nardulli A.M. Differential regulation of the human progesterone receptor gene through an estrogen response element half site and Sp1 sites. Journal of Steroid Biochemistry and Molecular Biology 88 (2004) 113-122
16. Rabe-Hesketh S., Skrondal A., and Pickles A. Reliable estimation of generalized linear mixed models using adaptive quadrature. The Stata Journal 2 (2002) 1-21
17. Riggs B.L., and Hartmann L.C. Selective estrogen-receptor modulators-mechanisms of action and application to clinical practice. New England Journal of Medicine 348 (2003) 618-629
18. Rossouw J.E., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. Journal of the American Medical Association 288 (2002) 321-333
19. Seo H.S., Denardo D.G., Jacquot Y., Laios I., Vidal D.S., Zambrana C.R., Leclercq G., Brown P.H., 2006. Stimulatory effect of genistein and apigenin on the growth of breast cancer cells correlates with their ability to activate ER alpha. Breast Cancer Research and Treatment March 16 [Epub ahead of print].
20. Setchell K.D., Clerici C., Lephart E.D., Cole S., Heenan C., Castellani D., Wolfe B.E., Nechemias-Zimmer L., Brown N.M., Lund T.D., Handa R.J., and Heubi J.E. S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. American Journal of Clinical Nutrition 81 (2005) 1072-1079
21. Shen P., Guo B.L., Gong Y., Hong Y., and Yong E.L. Taxonomic, genetic, chemical and estrogenic characteristics of Epimedium species. Phytochemistry 68 (2007) 1448-1458
22. Sonneveld E., Riteco J.A., Jansen H.J., et al. Comparison of in vitro and in vivo screening models for androgenic and estrogenic activities. Toxicological Sciences 89 (2006) 173-187
23. Wallace O.B., Lauwers K.S., Dodge J.A., et al. A selective estrogen receptor modulator for the treatment of hot flushes. Journal of Medicinal Chemistry 49 (2006) 843-846
24. Williamson G., and Manach C. Bioavailability and bioefficacy of polyphenols in humans II. Review of 93 intervention studies. American Journal of Clinical Nutrition 81 (2005) 243S-255S
25. Wong S.P., Li J., Shen P., Gong Y., Yap S.P., and Yong E.L. Ultrasensitive cell-based bioassay for the measurement of global estrogenic activity of flavonoid mixtures revealing additive, restrictive and enhanced actions in binary and higher order combinations. Assay and Drug Development Technologies 5 (2007) 355-362
26. Yap S.P., and Yong E.L. EB species. In: Packer L., Ong C.N., and Halliwell B. (Eds). Herbal and Traditional Medicine: Molecular Aspects of Health (2004), Marcel Dekker, New York 229-246
27. Yap S.P., Shen P., Butler M.S., Gong Y., Loy C.J., and Yong E.L. New estrogenic prenylflavone from EB brevicornum inhibits the growth of breast cancer cells. Planta Medica 71 (2005) 114-119
28. Zhang G., Qin L., Hung W.Y., Shi Y.Y., Leung P.C., Yeung H.Y., and Leung K.S. Flavonoids derived from herbal Epimedium Brevicornum Maxim prevent OVX-induced osteoporosis in rats independent of its enhancement in intestinal calcium absorption. Bone 38 (2006) 818-825
29. Zhang G., Qin L., and Shi Y. Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized double-blind and placebo-controlled trial. J Bone Miner Res (2007) 10.1359/jbmr.070405